Instil Bio, Inc.

TIL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $6.6M $8.8M $9.2M $43.7M $37.6M $241.7M
Accounts Receivable — — — — — —
Inventory — — — — — —
Total Current Assets $191.4M $124.5M $160.8M $269.4M $464.0M $246.1M
Property, Plant & Equipment $126.0K $129.4M $138.7M $196.9M $122.0M $55.3M
Goodwill — — — $0 $5.7M $5.7M
Intangible Assets (Excl. Goodwill) — — — — — —
Total Assets $203.5M $263.6M $325.6M $482.1M $610.0M $319.0M
Liabilities
Accounts Payable $779.0K $659.0K $1.2M $2.4M $5.6M $3.5M
Total Current Liabilities $4.8M $7.9M $10.6M $32.8M $41.4M $13.3M
Long-Term Debt — — — — — —
Total Liabilities $89.7M $94.1M $99.8M $118.5M $54.8M $26.6M
Stockholders' Equity
Retained Earnings $-726.5M $-655.1M $-581.0M $-424.9M $-201.7M $-44.9M
Total Stockholders' Equity $113.9M $169.4M $225.8M $363.6M $555.2M $-39.6M